This metabolite contains a PDE selectivity profile just like sildenafil and an in vitro potency for PDE5 approximately fifty% of the guardian drug. Plasma concentrations of this metabolite are around 40% of These found for sildenafil, so the metabolite accounts for about 20% of sildenafil’s pharmacologic effects.Unexpected vision reduction … Read More